Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 HKD | 0.00% | +1.96% | -21.21% |
04-22 | Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug | MT |
04-17 | Future Data Group Limited Announces Changes to its Board | CI |
Sales 2021 | 721M 92.05M 126M | Sales 2022 | 618M 78.9M 108M | Capitalization | 156M 19.93M 27.23M |
---|---|---|---|---|---|
Net income 2021 | 7M 894K 1.22M | Net income 2022 | -3M -383K -524K | EV / Sales 2021 | 0.1 x |
Net cash position 2021 | 35.36M 4.52M 6.17M | Net cash position 2022 | 56.95M 7.27M 9.94M | EV / Sales 2022 | 0.16 x |
P/E ratio 2021 |
14.9
x | P/E ratio 2022 |
-50.3
x | Employees | 243 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.53% |
1 week | +1.96% | ||
Current month | +20.93% | ||
1 month | +22.35% | ||
3 months | -10.34% | ||
6 months | -35.00% | ||
Current year | -21.21% |
Managers | Title | Age | Since |
---|---|---|---|
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Yuk Kan Lo
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xia Tao
CHM | Chairman | 50 | 22-10-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.52 | 0.00% | 785,000 |
24-04-25 | 0.52 | 0.00% | 735,000 |
24-04-24 | 0.52 | -1.89% | 780,000 |
24-04-23 | 0.53 | +1.92% | 550,000 |
24-04-22 | 0.52 | +1.96% | 720,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.21% | 36.31M | |
-7.42% | 31.57B | |
+0.21% | 15.14B | |
-6.71% | 8.91B | |
+6.83% | 7.48B | |
+3.85% | 4.94B | |
-45.75% | 4.44B | |
+12.35% | 2.99B | |
+8.53% | 2.44B | |
-13.45% | 2.36B |
- Stock Market
- Equities
- 8229 Stock